Gene · 6240
Papers3,003
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,003
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PTBP1 enforces ATR-CHK1 signaling determining the potency of CDC7 inhibitors. | iScience | 2023 | 37378325 | PubTator, text mining | PubMed |
| Binaphthyl-Based Chiral Macrocyclic Hosts for the Selective Recognition of Iodide Anions. | Molecules | 2023 | 37375339 | PubTator, text mining | PubMed |
| Prognostic Value of Chromatin Structure Typing in Early-Stage Non-Small Cell Lung Cancer. | Cancers (Basel) | 2023 | 37370781 | PubTator, text mining | PubMed |
| A missense mutation in RRM1 contributes to animal tameness. | Sci Adv | 2023 | 37352351 | PubTator, text mining | PubMed |
| Mutagenesis and structural studies reveal the basis for the specific binding of SARS-CoV-2 SL3 RNA element with human TIA1 protein. | Nat Commun | 2023 | 37349329 | PubTator, text mining | PubMed |
| BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCA-mutant ovarian cancer. | Sci Transl Med | 2023 | 37343085 | PubTator, text mining | PubMed |
| The crisscross between p53 and metabolism in cancer. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37337630 | PubTator, text mining | PubMed |
| Reversible promoter demethylation of PDGFD confers gemcitabine resistance through STAT3 activation and RRM1 upregulation. | Cancer Lett | 2023 | 37321532 | PubTator, text mining | PubMed |
| Splicing factor TRA2A contributes to esophageal cancer progression via a noncanonical role in lncRNA m6 A methylation. | Cancer Sci | 2023 | 37317053 | PubTator, text mining | PubMed |
| Inference for High-Dimensional Censored Quantile Regression. | J Am Stat Assoc | 2023 | 37309513 | PubTator, text mining | PubMed |
| Resistance of Leukemia Cells to 5-Azacytidine: Different Responses to the Same Induction Protocol. | Cancers (Basel) | 2023 | 37297025 | PubTator, text mining | PubMed |
| Essential role of bromodomain proteins in renal cell carcinoma (Review). | Mol Med Rep | 2023 | 37293842 | PubTator, text mining | PubMed |
| Compilation and functional classification of telomere length-associated genes in humans and other animal species. | Vavilovskii Zhurnal Genet Selektsii | 2023 | 37293446 | PubTator, text mining | PubMed |
| C11orf54 promotes DNA repair via blocking CMA-mediated degradation of HIF1A. | Commun Biol | 2023 | 37277441 | PubTator, text mining | PubMed |
| RPS15 interacted with IGF2BP1 to promote esophageal squamous cell carcinoma development via recognizing m6A modification. | Signal Transduct Target Ther | 2023 | 37264021 | PubTator, text mining | PubMed |
| Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma. | Pharmaceuticals (Basel) | 2023 | 37259439 | PubTator, text mining | PubMed |
| Looking for answers far away from the soma-the (un)known axonal functions of TDP-43, and their contribution to early NMJ disruption in ALS. | Mol Neurodegener | 2023 | 37259156 | PubTator, text mining | PubMed |
| Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm? | Front Pharmacol | 2023 | 37256234 | PubTator, text mining | PubMed |
| Structural insights into a regulatory mechanism of FIR RRM1-FUSE interaction. | Open Biol | 2023 | 37253421 | PubTator, text mining | PubMed |
| Inhibition of CDK9 exhibits anticancer activity in hepatocellular carcinoma cells via targeting ribonucleotide reductase. | Toxicol Appl Pharmacol | 2023 | 37245555 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6240/papers?page=13